These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. [Steatosis and steatohepatitis in diabetic patient]. Hůlek P; Dresslerová I Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059 [TBL] [Abstract][Full Text] [Related]
34. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Younossi ZM; Reyes MJ; Mishra A; Mehta R; Henry L Aliment Pharmacol Ther; 2014 Jan; 39(1):3-14. PubMed ID: 24206433 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis]. Kluwe J; Lohse AW Internist (Berl); 2005 Dec; 46(12):1324-30. PubMed ID: 16247633 [TBL] [Abstract][Full Text] [Related]
36. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Serfaty L; Lemoine M Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623 [TBL] [Abstract][Full Text] [Related]
37. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Crespo M; Lappe S; Feldstein AE; Alkhouri N Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580 [TBL] [Abstract][Full Text] [Related]